Mazen Noureddin
Gastroenterology · Houston, TX
CMS Profile ID: 235390 · NPI: 1205087087
Total Disclosed General Payments
$782,701.65
General-payment records
137
CMS Program Year
2025
The largest category was grants (about 45% of the total).
Payments by Type
| Payment Type | Amount |
|---|---|
| Grant | $349,500.00 |
| Acquisitions | $225,150.00 |
| Consulting Fee | $121,680.20 |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $43,468.19 |
| Travel and Lodging | $37,372.69 |
| Food and Beverage | $3,930.57 |
| Honoraria | $1,600.00 |
Top Paying Companies
| Manufacturer / GPO | Amount |
|---|---|
| Madrigal Pharmaceuticals | $421,232.52 |
| Novo Nordisk AS | $254,779.88 |
| Boehringer Ingelheim International GmbH | $38,408.36 |
| Merck Sharp & Dohme LLC | $23,346.71 |
| Novo Nordisk Inc | $21,899.66 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $14,434.28 |
Top contributing companies shown; smaller payers may be omitted.
These totals are computed from the official CMS Open Payments program-year 2025 general-payment
file. To see the full, authoritative record for this provider — including research payments and
line-item detail — look them up by exact NPI 1205087087 on the
official CMS Open Payments portal.
Verify this record with CMS
- Confirm the provider's exact NPI: 1205087087.
- Select program year 2025 and general payments in the CMS portal.
- Check individual payment records and their nature-of-payment categories.